Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Berta Casar

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Cancers|February 25, 2022
Combination of Resminostat with Ruxolitinib Exerts Antitumor Effects in the Chick Embryo Chorioallantoic Membrane Model for Cutaneous T Cell LymphomaFani Karagianni, Christina Piperi, Berta Casar, et al.
Molecular and Cellular Biology|December 31, 2008
Ras subcellular localization defines extracellular signal-regulated kinase 1 and 2 substrate specificity through distinct utilization of scaffold proteinsBerta Casar, Imanol Arozarena, Victoria Sanz-Moreno, et al.
Scientific Reports|March 22, 2021
Metallothionein-3 promotes cisplatin chemoresistance remodelling in neuroblastomaMiguel Angel Merlos Rodrigo, Hana Michalkova, Vladislav Strmiska, et al.
Molecular Oncology|September 12, 2024
ERK1/2 mitogen-activated protein kinase dimerization is essential for the regulation of cell motilityDalia de la Fuente-Vivas, Vincenzo Cappitelli, Rocío García-Gómez, et al.
Nature Communications|September 7, 2018
RAS at the Golgi antagonizes malignant transformation through PTPRκ-mediated inhibition of ERK activationBerta Casar, Andrew P Badrock, Iñaki Jiménez, et al.
Science Advances|February 15, 2023
Scaffold coupling: ERK activation by trans-phosphorylation across different scaffold protein speciesAna Martín-Vega, Laura Ruiz-Peinado, Rocío García-Gómez, et al.
Cancer Research|October 17, 2025
ZC3H13 Loss Drives Cancer Metastatic Progression by Disrupting m6A RNA MethylationÓscar Monteagudo-García, Paz Nombela, Ángel Carlos Román, et al.
The Journal of Investigative Dermatology|October 23, 2021
PLCγ1/PKCθ Downstream Signaling Controls Cutaneous T-Cell Lymphoma Development and ProgressionNuria García-Díaz, Berta Casar, Ruth Alonso-Alonso, et al.
Oncogene|March 20, 2021
ARID2 deficiency promotes tumor progression and is associated with higher sensitivity to chemotherapy in lung cancerThaidy Moreno, Beatriz Monterde, Laura González-Silva, et al.
Cancer Cell|August 13, 2015
Small Molecule Inhibition of ERK Dimerization Prevents Tumorigenesis by RAS-ERK Pathway OncogenesAna Herrero, Adán Pinto, Paula Colón-Bolea, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Cancers|February 25, 2022
Combination of Resminostat with Ruxolitinib Exerts Antitumor Effects in the Chick Embryo Chorioallantoic Membrane Model for Cutaneous T Cell LymphomaFani Karagianni, Christina Piperi, Berta Casar, et al.
Molecular and Cellular Biology|December 31, 2008
Ras subcellular localization defines extracellular signal-regulated kinase 1 and 2 substrate specificity through distinct utilization of scaffold proteinsBerta Casar, Imanol Arozarena, Victoria Sanz-Moreno, et al.
Scientific Reports|March 22, 2021
Metallothionein-3 promotes cisplatin chemoresistance remodelling in neuroblastomaMiguel Angel Merlos Rodrigo, Hana Michalkova, Vladislav Strmiska, et al.
Molecular Oncology|September 12, 2024
ERK1/2 mitogen-activated protein kinase dimerization is essential for the regulation of cell motilityDalia de la Fuente-Vivas, Vincenzo Cappitelli, Rocío García-Gómez, et al.
Nature Communications|September 7, 2018
RAS at the Golgi antagonizes malignant transformation through PTPRκ-mediated inhibition of ERK activationBerta Casar, Andrew P Badrock, Iñaki Jiménez, et al.
Science Advances|February 15, 2023
Scaffold coupling: ERK activation by trans-phosphorylation across different scaffold protein speciesAna Martín-Vega, Laura Ruiz-Peinado, Rocío García-Gómez, et al.
Cancer Research|October 17, 2025
ZC3H13 Loss Drives Cancer Metastatic Progression by Disrupting m6A RNA MethylationÓscar Monteagudo-García, Paz Nombela, Ángel Carlos Román, et al.
The Journal of Investigative Dermatology|October 23, 2021
PLCγ1/PKCθ Downstream Signaling Controls Cutaneous T-Cell Lymphoma Development and ProgressionNuria García-Díaz, Berta Casar, Ruth Alonso-Alonso, et al.
Oncogene|March 20, 2021
ARID2 deficiency promotes tumor progression and is associated with higher sensitivity to chemotherapy in lung cancerThaidy Moreno, Beatriz Monterde, Laura González-Silva, et al.
Cancer Cell|August 13, 2015
Small Molecule Inhibition of ERK Dimerization Prevents Tumorigenesis by RAS-ERK Pathway OncogenesAna Herrero, Adán Pinto, Paula Colón-Bolea, et al.
Pageof 3